Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Cancer Biologic Therapy Companies

Biological therapy, also known as immunotherapy, is a type of cancer treatment that uses the body's immune system to target and destroy cancer cells. Companies involved in global cancer biological therapy operate in the biotechnology and pharmaceutical sectors. They develop and manufacture biologically derived products, such as monoclonal antibodies, immune checkpoint inhibitors, and other immunotherapeutic agents, to treat various types of cancer.

Cancer Biological Therapy Companies

Latest Cancer Biological Therapy Companies Update:

Bristol Myers Squibb (US) acquires Turning Point Therapeutics (US) for $3.2 billion, gaining access to TP-598, a promising T-cell receptor therapy for solid tumors. (Jan 2024)

Roche (Switzerland) announces plans to purchase biotech company ImmunoGen (US) for $5.8 billion, strengthening its portfolio of antibody-drug conjugates for cancer treatment. (Dec 2023)

Pfizer (US) acquires cell therapy developer Vivant Biosciences (US) for $2.5 billion, aiming to expand its offerings in CAR-T cell therapy. (Nov 2023)

AstraZeneca (UK) receives FDA approval for Imfinzi (durvalumab) for the treatment of non-small cell lung cancer in combination with chemotherapy. (Jan 2024)

Merck & Co. (US) launches Keytruda (pembrolizumab) for the first-line treatment of advanced head and neck cancer. (Dec 2023)

Johnson & Johnson (US) unveils Tecentriq (atezolizumab) for the treatment of triple-negative breast cancer in combination with chemotherapy. (Nov 2023)

List of Cancer Biological Therapy companies in the market

Amgen Inc.

Bristol-Myers Squibb

Celgene Corporation

ELI Lilly and Company

Hoffmann-La Roche AG

EnGeneIC Ltd

Merck & Co. Inc.

Novartis, Pfizer Inc.

Cancer Biologic Therapy Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.